Differential leukotriene constrictor responses in human atherosclerotic coronary arteries.

BACKGROUND Leukotrienes are a class of biologically active lipids that have potent effects on the heart. To assess their role in coronary artery disease, we compared the contractile responses of leukotriene C4 (LTC4) and leukotriene D4 (LTD4) and their binding activity in both atherosclerotic and nonatherosclerotic human coronary arteries. We also studied expression of the enzymes that control their formation to understand how the 5-lipoxygenase (5-LO) pathway is activated in the coronary arteries. METHODS AND RESULTS The capacity of leukotrienes to affect coronary vessel tone and the influence of atherosclerosis was tested in organ baths. Leukotriene receptors were examined by autoradiography, and antibody binding to the various enzymes responsible for their formation was assessed by use of immunocytochemistry. Nonatherosclerotic coronary artery ring segments were unresponsive to LTC4 and LTD4. In contrast, LTC4 and LTD4 induced concentration-dependent contractions in atherosclerotic coronary arteries. Specific [3H]-LTC4 but not LTD4 binding to atherosclerotic coronary artery was evident, with no evidence of specific binding of [3H]-leukotrienes to nonatherosclerotic coronary artery. High-resolution autoradiography identified specific [3H]-LTC4 binding sites to smooth muscle cell and to regions of intimal proliferation and plaque. Cells showing positive antibody binding to 5-LO, FLAP (5-lipoxygenase activating protein), and leukotriene A4 hydrolase were also present in the coronary arteries and had a similar distribution to macrophages. CONCLUSIONS Atherosclerosis is associated with a specific leukotriene receptor(s) capable of inducing hyperreactivity of human epicardial coronary arteries in response to LTC4 and LTD4.

[1]  B. Koller,et al.  Role of the 5-Lipoxygenase–activating Protein (FLAP) in Murine Acute Inflammatory Responses , 1997, The Journal of experimental medicine.

[2]  M. Yacoub,et al.  Role of leukotrienes in coronary artery surgery. , 1995, Current opinion in cardiology.

[3]  A. Zeiher,et al.  Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. , 1995, Circulation.

[4]  M. Yacoub,et al.  Preferential Vasoconstriction to Cysteinyl Leukotrienes in the Human Saphenous Vein Compared With the Internal Mammary Artery: Implications for Graft Performance , 1994, Circulation.

[5]  K. Pritchard,et al.  Oxidized low density lipoprotein increases U937 cell 5-lipoxygenase activity: induction of 5-lipoxygenase activating protein. , 1994, Biochemical and biophysical research communications.

[6]  A. Takeshita,et al.  Hyperreactivity of aortic smooth muscle to serotonin is related to the presence of atheroma in Watanabe heritable hyperlipidaemic rabbits. , 1993, Cardiovascular research.

[7]  M. Yacoub,et al.  Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery , 1993, Coronary artery disease.

[8]  M. Yacoub,et al.  Influence of atherosclerosis on the vascular reactivity of isolated human epicardial coronary arteries to leukotriene C4. , 1993, Cardioscience.

[9]  V. Fuster,et al.  Coronary atherosclerosis : a multifactorial disease , 1993 .

[10]  C. E. Hock,et al.  Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion. , 1992, Cardiovascular research.

[11]  M. Yacoub,et al.  Effects of leukotrienes C4 and D4 on human isolated saphenous veins. , 1992, British journal of clinical pharmacology.

[12]  C. Serhan,et al.  Angioplasty Triggers Intracoronary Leukotrienes and Lipoxin A4: Impact of Aspirin Therapy , 1992, Circulation.

[13]  J. Kossmann,et al.  Differential low density lipoprotein receptor-dependent formation of eicosanoids in human blood-derived monocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Ford-hutchinson,et al.  Increased Urinary Leukotriene Excretion in Patients With Cardiac Ischemia: In Vivo Evidence for 5‐Lipoxygenase Activation , 1992, Circulation.

[15]  J. Cheng,et al.  Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[16]  A. Maseri,et al.  Coronary artery spasm and vasoconstriction. The case for a distinction. , 1990, Circulation.

[17]  A. Ford-hutchinson.  Leukotriene B4 in inflammation. , 1990, Critical reviews in immunology.

[18]  T. Springer,et al.  Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family. , 1989, The Journal of clinical investigation.

[19]  P. Cannon,et al.  Leukotriene biosynthesis by canine and human coronary arteries. , 1987, The Journal of pharmacology and experimental therapeutics.

[20]  E. Corey,et al.  Identification of a high affinity leukotriene C4-binding protein in rat liver cytosol as glutathione S-transferase. , 1986, The Journal of biological chemistry.

[21]  K. Austen,et al.  Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. , 1986, Advances in immunology.

[22]  W. Nichols,et al.  Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. , 1985, Journal of the American College of Cardiology.

[23]  C. Rouzer,et al.  On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Folco,et al.  Identification of specific binding sites for leukotriene C4 in membranes from human lung. , 1985, Biochemical pharmacology.

[25]  K. Austen,et al.  Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid omega-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. , 1985, The Journal of biological chemistry.

[26]  P. Needleman,et al.  Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. , 1985, The Journal of clinical investigation.

[27]  A. Weerheim,et al.  Suppression of cholesteryl ester accumulation in cultured human monocyte-derived macrophages by lipoxygenase inhibitors. , 1985, Biochemical and biophysical research communications.

[28]  R. Townley,et al.  Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations. , 1985, The Journal of pharmacology and experimental therapeutics.

[29]  A. Lefer,et al.  Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocardium. , 1985, Circulatory shock.

[30]  A. M. Lefer,et al.  Studies on the mechanism of leukotriene induced coronary artery constriction. , 1983, Prostaglandins.

[31]  R. Egan,et al.  Leukotriene C4 binding to rat lung membranes. , 1983, The Journal of biological chemistry.

[32]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[33]  E. Corey,et al.  Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. , 1982, The Journal of pharmacology and experimental therapeutics.

[34]  S. Epstein,et al.  Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris. , 1981, The American journal of cardiology.

[35]  E. Corey,et al.  Leukotriene B. Total synthesis and assignment of stereochemistry , 1980 .

[36]  Robert A. Lewis,et al.  Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. , 1980, Biochemical and biophysical research communications.

[37]  H. Morris,et al.  Structure of slow-reacting substance of anaphylaxis from guinea-pig lung , 1980, Nature.

[38]  A. Yunis,et al.  The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501). , 1980, Research communications in chemical pathology and pharmacology.

[39]  R. Murphy,et al.  Leukotriene C: a slow-reacting substance from murine mastocytoma cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Specchia,et al.  Coronary Arterial Spasm as a Cause of Exercise‐Induced ST‐Segment Elevation in Patients with Variant Angina , 1979, Circulation.

[41]  B. Samuelsson,et al.  Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. , 1979, The Journal of biological chemistry.